Leef Brands (LEEEF) Net Cash Flow (2025 - 2026)
Leef Brands' (LEEEF) quarterly Net Cash Flow came in at $3.6 million in Q1 2026, up 296.28% year-on-year from $899673.1 in Q1 2025, and up 296.28% quarter-over-quarter from -$1.8 million in Q1 2025.
Leef Brands (LEEEF) Net Cash Flow (2025 - 2026) Analysis & Trends
Leef Brands has disclosed Net Cash Flow across 2 years of filings, most recently posting $3.6 million for Q1 2026.
- Net Cash Flow for Q1 2026 came in at $3.6 million, up 296.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed N/A YoY), and the FY2025 annual result was -$540914.0, up 85.34% from the prior year.
- Net Cash Flow came in at $3.6 million for Q1 2026 at Leef Brands, up from -$1.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $3.6 million in Q1 2026 to a low of -$1.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Leef Brands | - | - | 4.62 Mn | 3.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.57 Mn |
| Mar 31, 2026 | 3.57 Mn |
| Mar 31, 2025 | -1.82 Mn |
| Mar 31, 2025 | -1.82 Mn |